Swiss National Bank Antares Pharma, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	N/A	-382,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	N/A	27,700 Added 7.82%	382,000 $1.57 Million
Q3 2021 Nov 08, 2021	BUY	N/A	5,300 Added 1.52%	354,300 $1.29 Million
Q2 2021 Aug 06, 2021	SELL	N/A	-12,800 Reduced 3.54%	349,000 $1.52 Million
Q1 2021 May 07, 2021	BUY	N/A	5,300 Added 1.49%	361,800 $1.49 Million
Q3 2020 Nov 09, 2020	BUY	N/A	10,400 Added 3.0%	356,500 $963,000
Q2 2020 Aug 05, 2020	BUY	N/A	45,400 Added 15.1%	346,100 $952,000
Q1 2020 May 08, 2020	BUY	N/A	4,200 Added 1.42%	300,700 $710,000
Q4 2019 Feb 06, 2020	BUY	N/A	6,700 Added 2.31%	296,500 $1.39 Million
Q3 2019 Nov 12, 2019	BUY	N/A	11,300 Added 4.06%	289,800 $969,000
Q2 2019 Aug 02, 2019	BUY	N/A	20,100 Added 7.78%	278,500 $916,000
Q1 2019 May 10, 2019	BUY	N/A	7,900 Added 3.15%	258,400 $783,000
Q4 2018 Feb 13, 2019	BUY	N/A	250,500 New	250,500 $681,000

About Antares Pharma, Inc.

Ticker ATRS
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 170,042,000
Market Cap $951M

More about ATRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.